bpc-157 clinical trial knee pain Can you inject peptides into the knee? Injectable BPC-157: Better for Knee

Chen Q-Y, Jiao D-M, Wang J, Hu H, Tang X, Chen J, et al

The content provided in this article is for educational and informational purposes only and is based on published scientific literature

Post-surgical recovery affecting multiple tissue types, chronic widespread inflammation, and patients whose primary complaint is global stiffness and reduced range of motion that has not improved with localized treatment all fit the TB-500 indication

In clinical research, that effect is often reflected through body weight reduction and waist circumference change over defined protocol windows, and those endpoints are exactly what the phase 2 cagrilintide trial reported

BPC-157 and TB-500 have a 60-day window

Its interest stems from pre-clinical research showing tissue-repair, anti-inflammatory, cytoprotective and angiogenic effects in animal models